Viktor Bogdanov

Dr. Viktor Bogdanov

Endocrinology Research Centre
+1
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2017 in The Journal of Physical Chemistry Letters
Verified
Journal Article
Closed access
HYHuanqing Ye
Huanqing Ye
VBViktor Bogdanov
Viktor Bogdanov
SLSheng Liu
Sheng Liu
SVSaumitra Vajandar
Saumitra Vajandar
TOThomas Osipowicz
Thomas Osipowicz
QXQihua Xiong
Qihua Xiong

22 July 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
APAlexandra Povaliaeva
Alexandra Povaliaeva
VBViktor Bogdanov
Viktor Bogdanov
EPEKATERINA PIGAROVA
EKATERINA PIGAROVA
LDLarisa K Dzeranova
Larisa K Dzeranova
NKNino Katamadze
Nino Katamadze
NMNatalia G. Mokrysheva
Natalia G. Mokrysheva
There is increasing data regarding the association between vitamin D and COVID-19. This study aimed to reveal the alterations of vitamin D metabolism in the setting of COVID-19. We examined 119 adult COVID-19 inpatients and 44 apparently healthy adult individuals with similar serum 25OH-D3 levels as a reference group. The assessment included serum biochemical parameters (total calcium, albumin, phosphorus, creatinine), parathyroid hormone (PTH), vitamin D-binding protein (DBP), vitamin D metabolites (25OH-D3, 25OH-D2, 1,25(OH)2D3, 3-epi-25OH-D3, 24,25(OH)2D3 and D3) and free 25OH-D. COVID-19 patients had in general very low vitamin D levels (median 25OH-D3 equals 10.8 ng/mL), accompanied by an increased production of the active vitamin D metabolite (1,25(OH)2D3), estimated as higher 1,25(OH)2D3 serum levels (61 [44; 81] vs. 40 [35; 50] pg/mL, p < 0.001) and lower 25OH-D3/1,25(OH)2D3 ratio (175 [112; 260] vs. 272 [200; 433], p < 0.001) which is presumably aimed at preventing hypocalcemia. Patients with COVID-19 also had elevated DBP (450 [386; 515] vs. 392 [311; 433] mg/L, p < 0.001) and low free 25OH-D levels (<LoB vs. 3.9 [3.2; 4.4] pg/mL, p < 0.001). Follow-up assessment of the COVID-19 inpatients showed recovery of the observed changes. Overall, hospitalized patients with an acute course of COVID-19 have not only very low levels of 25OH-D but also profound abnormalities in the metabolism of vitamin D regardless of the clinical course of the disease. These alterations might exacerbate existing vitamin D deficiency and its negative impact.

1 November 2016 in Electrochimica Acta
Verified
Journal Article
Closed access
VBV.A. Brotsman
V.A. Brotsman
VIV.A. Ioutsi
V.A. Ioutsi
ARA.V. Rybalchenko
A.V. Rybalchenko
VBViktor Bogdanov
Viktor Bogdanov
SSS.A. Sokolov
S.A. Sokolov
AGAlexey Goryunkov
Alexey Goryunkov

18 December 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
APAlexandra Povaliaeva
Alexandra Povaliaeva
EPEKATERINA PIGAROVA
EKATERINA PIGAROVA
AZArtem Zhukov
Artem Zhukov
VBViktor Bogdanov
Viktor Bogdanov
LDLarisa K Dzeranova
Larisa K Dzeranova
LRLiudmila Rozhinskaya
Liudmila Rozhinskaya
In this prospective controlled study, we examined 25 adults with adequately controlled (HbA1c level < 8.0%) type 1 diabetes mellitus (T1DM) and 49 conditionally healthy adults, intending to reveal the diversity of vitamin D metabolism in the setting of cholecalciferol intake at a therapeutic dose. All patients received a single dose (150,000 IU) of cholecalciferol aqueous solution orally. Laboratory assessments including serum vitamin D metabolites (25(OH)D3, 25(OH)D2, 1,25(OH)2D3, 3-epi-25(OH)D3 and 24,25(OH)2D3), free 25(OH)D, vitamin D-binding protein (DBP) and parathyroid hormone (PTH) as well as serum and urine biochemical parameters were performed before the intake and on Days 1, 3 and 7 after the administration. The studied groups had no significant differences in baseline parameters except that the patients with diabetes showed higher baseline levels of free 25(OH)D (p < 0.05). They also lacked a correlation between the measured and calculated free 25(OH)D in contrast to the patients from the control group (r = 0.41, p > 0.05 vs. r = 0.88, p < 0.05), possibly due to the glycosylation of binding proteins, which affects the affinity constant for 25(OH)D. The elevation of vitamin D levels after the administration of cholecalciferol was comparable in both groups, with slightly higher 25(OH)D3 levels observed in the diabetes group throughout the study since Day 1 (p < 0.05). Overall, our data indicate that in patients with adequately controlled T1DM 25(OH)D3 levels and the therapeutic response to cholecalciferol is similar to that in healthy individuals.

9 May 2016 in Chemistry – An Asian Journal
Verified
Journal Article
Closed access
PDF file
VBVictor Brotsman
Victor Brotsman
VBViktor Bogdanov
Viktor Bogdanov
ARAlexey V. Rybalchenko
Alexey V. Rybalchenko
EGEvgenia P. Galanicheva
Evgenia P. Galanicheva
NBNikita M. Belov
Nikita M. Belov
AGAlexey Goryunkov
Alexey Goryunkov

8 September 2016 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
VBViktor Bogdanov
Viktor Bogdanov
OSOlesya O. Semivrazhskaya
Olesya O. Semivrazhskaya
NBNikita M. Belov
Nikita M. Belov
STSergey I. Troyanov
Sergey I. Troyanov
VMVitaliy Yu. Markov
Vitaliy Yu. Markov
AGAlexey Goryunkov
Alexey Goryunkov